These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Large induces functional glycans in an O-mannosylation dependent manner and targets GlcNAc terminals on alpha-dystroglycan. Hu Y; Li ZF; Wu X; Lu Q PLoS One; 2011 Feb; 6(2):e16866. PubMed ID: 21347376 [TBL] [Abstract][Full Text] [Related]
23. Protein glycosylation in disease: new insights into the congenital muscular dystrophies. Martin-Rendon E; Blake DJ Trends Pharmacol Sci; 2003 Apr; 24(4):178-83. PubMed ID: 12707004 [TBL] [Abstract][Full Text] [Related]
24. Human ISPD Is a Cytidyltransferase Required for Dystroglycan O-Mannosylation. Riemersma M; Froese DS; van Tol W; Engelke UF; Kopec J; van Scherpenzeel M; Ashikov A; Krojer T; von Delft F; Tessari M; Buczkowska A; Swiezewska E; Jae LT; Brummelkamp TR; Manya H; Endo T; van Bokhoven H; Yue WW; Lefeber DJ Chem Biol; 2015 Dec; 22(12):1643-52. PubMed ID: 26687144 [TBL] [Abstract][Full Text] [Related]
25. O-mannosyl phosphorylation of alpha-dystroglycan is required for laminin binding. Yoshida-Moriguchi T; Yu L; Stalnaker SH; Davis S; Kunz S; Madson M; Oldstone MB; Schachter H; Wells L; Campbell KP Science; 2010 Jan; 327(5961):88-92. PubMed ID: 20044576 [TBL] [Abstract][Full Text] [Related]
26. Protein O-mannosylation: one sugar, several pathways, many functions. Koff M; Monagas-Valentin P; Novikov B; Chandel I; Panin V Glycobiology; 2023 Dec; 33(11):911-926. PubMed ID: 37565810 [TBL] [Abstract][Full Text] [Related]
27. Initiation of mammalian O-mannosylation in vivo is independent of a consensus sequence and controlled by peptide regions within and upstream of the alpha-dystroglycan mucin domain. Breloy I; Schwientek T; Gries B; Razawi H; Macht M; Albers C; Hanisch FG J Biol Chem; 2008 Jul; 283(27):18832-40. PubMed ID: 18456664 [TBL] [Abstract][Full Text] [Related]
28. Development of rabbit monoclonal antibodies for detection of alpha-dystroglycan in normal and dystrophic tissue. Fortunato MJ; Ball CE; Hollinger K; Patel NB; Modi JN; Rajasekaran V; Nonneman DJ; Ross JW; Kennedy EJ; Selsby JT; Beedle AM PLoS One; 2014; 9(5):e97567. PubMed ID: 24824861 [TBL] [Abstract][Full Text] [Related]
29. B4GAT1 is the priming enzyme for the LARGE-dependent functional glycosylation of α-dystroglycan. Praissman JL; Live DH; Wang S; Ramiah A; Chinoy ZS; Boons GJ; Moremen KW; Wells L Elife; 2014 Oct; 3():. PubMed ID: 25279697 [TBL] [Abstract][Full Text] [Related]
30. GTDC2 modifies O-mannosylated α-dystroglycan in the endoplasmic reticulum to generate N-acetyl glucosamine epitopes reactive with CTD110.6 antibody. Ogawa M; Nakamura N; Nakayama Y; Kurosaka A; Manya H; Kanagawa M; Endo T; Furukawa K; Okajima T Biochem Biophys Res Commun; 2013 Oct; 440(1):88-93. PubMed ID: 24041696 [TBL] [Abstract][Full Text] [Related]
31. ISPD gene mutations are a common cause of congenital and limb-girdle muscular dystrophies. Cirak S; Foley AR; Herrmann R; Willer T; Yau S; Stevens E; Torelli S; Brodd L; Kamynina A; Vondracek P; Roper H; Longman C; Korinthenberg R; Marrosu G; Nürnberg P; ; Michele DE; Plagnol V; Hurles M; Moore SA; Sewry CA; Campbell KP; Voit T; Muntoni F Brain; 2013 Jan; 136(Pt 1):269-81. PubMed ID: 23288328 [TBL] [Abstract][Full Text] [Related]
32. Dystroglycan glycosylation and muscular dystrophy. Moore CJ; Hewitt JE Glycoconj J; 2009 Apr; 26(3):349-57. PubMed ID: 18773291 [TBL] [Abstract][Full Text] [Related]
33. The dystroglycanopathies: the new disorders of O-linked glycosylation. Martin PT Semin Pediatr Neurol; 2005 Sep; 12(3):152-8. PubMed ID: 16584074 [TBL] [Abstract][Full Text] [Related]
34. Probing the stability of the "naked" mucin-like domain of human α-dystroglycan. Bozzi M; Di Stasio E; Scaglione GL; Desiderio C; Martelli C; Giardina B; Sciandra F; Brancaccio A BMC Biochem; 2013 Jul; 14():15. PubMed ID: 23815856 [TBL] [Abstract][Full Text] [Related]
35. O-Mannose and O-N-acetyl galactosamine glycosylation of mammalian α-dystroglycan is conserved in a region-specific manner. Gomez Toledo A; Raducu M; Cruces J; Nilsson J; Halim A; Larson G; Rüetschi U; Grahn A Glycobiology; 2012 Nov; 22(11):1413-23. PubMed ID: 22781125 [TBL] [Abstract][Full Text] [Related]
36. Mechanisms of disease: congenital muscular dystrophies-glycosylation takes center stage. Martin PT Nat Clin Pract Neurol; 2006 Apr; 2(4):222-30. PubMed ID: 16932553 [TBL] [Abstract][Full Text] [Related]
37. [Dystroglycan linkage and muscular dystrophy]. Shimizu T Rinsho Shinkeigaku; 2002 Nov; 42(11):1091-4. PubMed ID: 12784674 [TBL] [Abstract][Full Text] [Related]
38. Protein O-mannosylation is crucial for E-cadherin-mediated cell adhesion. Lommel M; Winterhalter PR; Willer T; Dahlhoff M; Schneider MR; Bartels MF; Renner-Müller I; Ruppert T; Wolf E; Strahl S Proc Natl Acad Sci U S A; 2013 Dec; 110(52):21024-9. PubMed ID: 24297939 [TBL] [Abstract][Full Text] [Related]
39. O Mannosylation of alpha-dystroglycan is essential for lymphocytic choriomeningitis virus receptor function. Imperiali M; Thoma C; Pavoni E; Brancaccio A; Callewaert N; Oxenius A J Virol; 2005 Nov; 79(22):14297-308. PubMed ID: 16254364 [TBL] [Abstract][Full Text] [Related]